AU Stock MarketDetailed Quotes

TLX Telix Pharmaceuticals Ltd

Watchlist
  • 24.740
  • -0.930-3.62%
20min DelayMarket Closed Dec 20 16:00 AET
8.28BMarket Cap1546.25P/E (Static)

Telix Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Telix Pharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 419.800M--
--2024/Q4-- / 390.800M--
Aug 23, 20232023/Q2120.700M / ----
Feb 27, 20232022/Q480.749M / 68.850M--
Oct 20, 20222022/Q355.300M / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 419.800M--
--2024/Q4-- / 390.800M--
Aug 23, 20232023/Q2120.700M / ----
Feb 27, 20232022/Q480.749M / 68.850M--
Oct 20, 20222022/Q355.300M / ----

Unlock Free Earnings Estimates

Telix Pharmaceuticals Ltd Earnings Reports

  • Telix Pharmaceuticals Ltd: Telix Q3 2024 Revenue and Business Update

    Oct 17 02:08 ET

  • Telix Pharmaceuticals Ltd: Telix 1H 2024 Results Presentation

    Aug 22 02:42 ET

  • Telix Pharmaceuticals Ltd: Telix 1H 2024 Results Release

    Aug 22 02:41 ET

  • Telix Pharmaceuticals Ltd: Telix 1H 2024 Appendix 4D and Interim Report

    Aug 22 02:40 ET

    • Read more

    Trending AU Stocks
    ASX High Dividend ASX High Dividend
    Symbol Mini Chart % Chg
    Fortescue Ltd
    FMG
    +1.96%
    Woodside Energy Group Ltd
    WDS
    +1.95%
    Origin Energy Ltd
    ORG
    +1.35%
    Telstra Group Ltd
    TLS
    +0.25%
    BHP Group Ltd
    BHP
    -0.23%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Nov 16, 2024

    Buy

    • Strong Buy

      77.78%

    • Buy

      0.00%

    • Hold

      11.11%

    • Underperform

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Healthcare - Cancer Research
    Healthcare - Cancer Research
    Intraday-1.42%